Breakthrough Blood Test Predicts Lung Cancer Five Years Before Clinical Diagnosis

Revolutionizing Early Detection An international team of researchers, led by molecular biologist Yago Garitaonaindia, announced on June 9, 2026, the development of a highly sensitive blood-based diagnostic test capable of identifying lung cancer risk up to five years before traditional clinical symptoms appear. The study, published across multiple medical platforms, utilizes advanced molecular profiling to…

Read More
EASL 2026: Hepatitis C Testing Barriers Delay Early Treatment

EASL 2026: Hepatitis C Testing Barriers Delay Early Treatment

Diagnostic Bottlenecks in Global Viral Hepatitis Elimination At the 2026 European Association for the Study of the Liver (EASL) Congress, international health experts identified critical structural and systemic barriers in hepatitis C virus (HCV) testing that continue to obstruct progress toward World Health Organization (WHO) elimination goals. Despite the availability of highly effective direct-acting antivirals,…

Read More